BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33812258)

  • 21. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
    Lavi Arab F; Rastin M; Faraji F; Zamani Taghizadeh Rabe S; Tabasi N; Khazaee M; Haghmorad D; Mahmoudi M
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):12-8. PubMed ID: 25318538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study.
    Kang Y; Yan Q; Fu Q; Wang R; Dai M; Du F; Dai Q; Ye P; Wu C; Lu L; Bao C
    Arthritis Res Ther; 2020 Mar; 22(1):65. PubMed ID: 32228698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
    Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
    Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
    Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
    Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
    Chen M; Chen X; Wan Q
    Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function.
    Song X; Gao J; Liu H; Liu X; Tang K
    Biomed Pharmacother; 2021 May; 137():111289. PubMed ID: 33581650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study).
    Yan Q; Du F; Kang Y; Ye P; Wang X; Xu J; Tang J; Wang N; Jiang G; Li Z; Wang X; Xue Q; Huang X; Zhang X; Zhou Y; Dai M; Bao C
    Trials; 2021 Aug; 22(1):530. PubMed ID: 34380536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
    Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O
    Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disabled-2 overexpression mediates immune suppression in systemic lupus erythematosus by modulating Treg/Th17 cell differentiation.
    Zhang J; Chang L; Sun Y; Qin M; Wang X; Guo Y
    Clin Exp Pharmacol Physiol; 2022 May; 49(5):596-607. PubMed ID: 35108421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
    Bashi T; Blank M; Ben-Ami Shor D; Fridkin M; Versini M; Gendelman O; Volkov A; Barshak I; Shoenfeld Y
    J Autoimmun; 2015 May; 59():1-7. PubMed ID: 25864802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus.
    Kleczynska W; Jakiela B; Plutecka H; Milewski M; Sanak M; Musial J
    Folia Histochem Cytobiol; 2011; 49(4):646-53. PubMed ID: 22252759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease.
    Nasa Y; Satake A; Tsuji R; Saito R; Tsubokura Y; Yoshimura H; Ito T
    Front Immunol; 2024; 15():1326066. PubMed ID: 38665907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z; Liu D; Zhang X; Wang X
    Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3
    Zhou X; Chen H; Wei F; Zhao Q; Su Q; Liang J; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
    J Immunol Res; 2019; 2019():2431617. PubMed ID: 31240232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
    Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
    Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.